(Q57261221)

English

T.P.1 02 A phase I/II clinical trial in Duchenne muscular dystrophy using IM and IV delivered antisense oligonucleotides: The MDEX consortium

No description defined

In more languages
default for all languages
No label defined

No description defined

Statements

T.P.1 02 A phase I/II clinical trial in Duchenne muscular dystrophy using IM and IV delivered antisense oligonucleotides: The MDEX consortium (English)
0 references
V. Arechavala
0 references
K. Bushby
0 references
G. Dickson
0 references
I. Graham
0 references
M. Kinali
0 references
K. Liu
0 references
J. Morgan
0 references
L. Popplewell
0 references
T. Partridge
0 references
F. Thorogood
0 references
K. Wells
0 references
N. Wells
0 references
M. Wood
0 references
H. Yin
0 references
October 2006
0 references
16
0 references
9-10
0 references
685
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit